The studies, published in renowned scientific journals, produced astounding results and altered the course of research into the coronavirus pandemic. One undercut President Trump’s claim that certain antimalarial drugs cure Covid-19, the illness caused by the virus, concluding that the medications in fact were dangerous to patients. The other found that some blood pressure drugs… Read More »
The news: Patients have started to receive the first antibody drug developed specifically to treat covid-19. It’s being tested in 32 patients at various doses in hospitals in the US. If it’s shown to be safe, the drug, referred to as LY-CoV555, will be studied in non-hospitalized coronavirus patients later this summer. The big idea:… Read More »
The barbershop and beauty salon are important community touch points for health, wellness, and social connection in so many peoples’ lives. In my book, HealthConsuming: From Health Consumer to Health Citizen, I feature the black barbershop to introduce a chapter on “The New Retail Health.” In the COVID-19 pandemic, how we’re dealing with hair is… Read More »
The technology has matured enough, and the algorithms have been honed in recent years, to the point where there are now two types of artificial intelligence: “old school AI and new school AI,” as medical journalist Paul Cerrato proposed during a recent HIMSS20 Digital Session. For examples of the former, think DeepBlue – the chess-playing… Read More »
By Clare Wilson Ventilators have been seen as a crucial tool for treating severe cases of covid-19, but they may not always be neededBuda Mendes/Getty Images When the coronavirus pandemic began, the UK scrambled to get more ventilators for intensive care. But now some doctors are trying to keep people off ventilators as they believe… Read More »
According to many public health experts, testing for COVID-19 is key to stopping the pandemic. Testing leads to quick identification, isolation and treatment of COVID-19 cases, including those who came into contact with infected people. It stops the spread of the virus.1 Unfortunately, widespread testing in the U.S. has been limited by logistic and personnel… Read More »
After scoring an early authorization for its COVID-19 therapy remdesivir, Gilead Sciences has been on the hunt for manufacturing partners to help boost production. Through a series of licensing agreements with generics makers, Gilead has taken the first steps to build that network. Gilead signed nonexclusive licensing agreements with five generic drug makers operating in India and… Read More »